| Sign In to gain access to subscriptions and/or personal tools. |
Irbesartan attenuates Ang II-induced BMP-2 expression in human umbilical vein endothelial cellsDepartment of Cardiology, Second Xiangya Hospital, Central South University, Changsha, Hunan, China
Department of Cardiology, Second Xiangya Hospital, Central South University, Changsha, Hunan, China
Department of Cardiology, Second Xiangya Hospital, Central South University, Changsha, Hunan, China
Department of Cardiology, Second Xiangya Hospital, Central South University, Changsha, Hunan, China
Department of Cardiology, Second Xiangya Hospital, Central South University, Changsha, Hunan, China
Department of Cardiology, Second Xiangya Hospital, Central South University, Changsha, Hunan, China Abstract
Bone morphogenetic protein-2 (BMP-2), a transforming growth factor-β superfamily member cytokine, plays a key role both in vascular development and in pathophysiological processes. However, the effects and mechanisms of angiotensin II (Ang II) on BMP-2 expression remain unknown in human umbilical vein endothelial cells (HUVECs). Here we show that Ang II treatment significantly increased BMP-2 expression, associated with NF-
Key Words: Ang II BMP-2 HUVECs irbesartan
Vascular Medicine, Vol. 13, No. 3,
239-245 (2008) |
||||
B activation, which was suppressed by treatment with pyrrolidine dithiocarbamate (PDTC) or irbesartan. Furthermore, the increased levels of MDA (malondialdehyde) in conditioned media and the decrease in activities of total superoxide dismutases (SOD) caused by Ang II were reversed by irbesartan or PDTC treatment. Our findings indicate that Ang II-induced BMP-2 expression might contribute to NF-